Controlled release of active substances

Controlled release of active substances refers to a pharmaceutical technology and formulation strategy designed to regulate the timing, rate, and location of drug delivery within the body. It is not a biological molecule, receptor, or enzyme, but rather a mechanism used to optimize the therapeutic index of drugs by maintaining stable plasma concentrations over an extended period. This approach is instrumental in treating chronic conditions, such as diabetes and hypertension, where frequent dosing of immediate-release medications would lead to poor compliance or adverse effects from concentration spikes. Delivery systems often involve the use of specialized polymers, hydrogels, liposomes, or osmotic pumps that release the active ingredient via diffusion, erosion, or external triggers (Source: NCBI, PubMed). While it enhances drug efficacy and safety, significant challenges include the risk of dose dumping and ensuring the long-term biocompatibility of the delivery materials. Ultimately, controlled release systems represent a cornerstone of modern nanomedicine and pharmacology, bridging the gap between drug discovery and effective clinical application.

Other names

Controlled-release drug deliveryModified-release dosage formsSustained releaseExtended releaseDrug delivery systemsTargeted drug delivery

Controlled release systems utilize physicochemical mechanisms to regulate drug delivery, including diffusion-controlled systems (where the drug passes through a polymer membrane), chemically-controlled systems (involving the bioerosion or degradation of a matrix), solvent-activated systems (osmotic pressure or swelling), and ion-exchange resins (Source: StatPearls - Drug Delivery Systems).